"Ovary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
| Descriptor ID |
D010053
|
| MeSH Number(s) |
A05.360.319.114.630 A05.360.576.497 A06.407.312.497
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ovary".
Below are MeSH descriptors whose meaning is more specific than "Ovary".
This graph shows the total number of publications written about "Ovary" by people in this website by year, and whether "Ovary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 4 | 7 |
| 1998 | 1 | 2 | 3 |
| 1999 | 2 | 2 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 3 | 5 |
| 2007 | 2 | 2 | 4 |
| 2008 | 2 | 0 | 2 |
| 2009 | 4 | 6 | 10 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 2 | 5 |
| 2012 | 3 | 6 | 9 |
| 2013 | 2 | 2 | 4 |
| 2014 | 5 | 2 | 7 |
| 2015 | 5 | 0 | 5 |
| 2016 | 6 | 4 | 10 |
| 2017 | 2 | 3 | 5 |
| 2018 | 2 | 2 | 4 |
| 2019 | 4 | 0 | 4 |
| 2020 | 0 | 3 | 3 |
| 2021 | 2 | 3 | 5 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ovary" by people in Profiles.
-
Modeling the extension of ovarian function after therapeutic targeting of the primordial follicle reserve. Hum Reprod Update. 2025 Sep 01; 31(5):464-477.
-
Delineating lipidomic landscapes in human and mouse ovaries: Spatial signatures and chemically-induced alterations via MALDI mass spectrometry imaging: Spatial ovarian lipidomics. Environ Int. 2024 Dec; 194:109174.
-
Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause. Int J Mol Sci. 2024 Jun 27; 25(13).
-
Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model. Am J Obstet Gynecol. 2024 07; 231(1):111.e1-111.e18.
-
Small Bowel Adenocarcinoma Metastatic to the Ovaries: A Challenging Diagnosis. Ultraschall Med. 2023 08; 44(4):e206-e208.
-
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Rep. 2022 12 20; 41(12):111838.
-
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor. Gynecol Oncol. 2023 02; 169:98-105.
-
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor. Gynecol Oncol. 2022 07; 166(1):117-125.
-
Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer. PLoS One. 2021; 16(7):e0255007.
-
Repeated loss of variation in insect ovary morphology highlights the role of development in life-history evolution. Proc Biol Sci. 2021 05 12; 288(1950):20210150.